NFKB1 and amyotrophic lateral sclerosis: The data presented above indicate that astroglial inhibition of NF-κB does not affect motor neuron survival in an ALS genetic model, although astrocyte dysfunction, via a number of pathways including the NF-κB one, has been invoked as a potential mediator of disease progression.